Publications by authors named "Maria Chernovsky"

Claim this Profile
F
First evaluation of microvascular damage through nailfold capillaroscopy of an uncommon case of Raynaud's phenomenon in multiple sclerosis: Case report and literature review.
Lucrezia Mondini, Gianluca Screm, Francesco Salton, Paola Confalonieri, Maria Chernovsky

Clin Hemorheol Microcirc· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comorbidities' Effect on IPF: Pathogenesis and Management.
Andrea Salotti, Maria Chianese, Antonio Romallo, Anna De Nes, Darina Angoni, Maria Chernovsky

Biomedicines· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Comorbidities on the Discontinuation of Antifibrotic Therapy in Patients with Idiopathic Pulmonary Fibrosis.
Stefano Kette, Nicolò Reccardini, Francesco Salton, Paola Confalonieri, Alessia Andrisano, Maria Chernovsky

Pharmaceuticals (Basel)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alveolar nitric oxide concentration as a potential biomarker of fibrosis and active disease in pulmonary sarcoidosis: a pilot study.
Stefano Levra, Fabiana Giannoccaro, Maria Chernovsky, Vitina Carriero, Elisa Arrigo

J Breath Res· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gastrointestinal Manifestations of Sarcoidosis: A State-of-the-Art, Comprehensive Review of the Literature-Practical Clinical Insights and Many Unmet Needs on Diagnosis and Treatment.
Salvatore Nicolosi, Maria Chernovsky, Darina Angoni, Michael Hughes, Giulia Bandini

Pharmaceuticals (Basel)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of Nintedanib in a Patient with Chronic Pulmonary Fibrosis and Kidney Disease.
Marta Maggisano, Lucrezia Mondini, Maria Chernovsky, Paola Confalonieri, Francesco Salton

Pharmaceuticals (Basel)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pirfenidone in Idiopathic Pulmonary Fibrosis: Real-World Observation on Efficacy and Safety, Focus on Patients Undergoing Antithrombotic and Anticoagulant.
Nicolò Reccardini, Maria Chernovsky, Francesco Salton, Paola Confalonieri, Lucrezia Mondini

Pharmaceuticals (Basel)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis